Literature DB >> 21963265

Clinical characteristics of a large cohort of patients with scleritis and episcleritis.

Maite Sainz de la Maza1, Nicolas Molina, Luis Alonso Gonzalez-Gonzalez, Priyanka P Doctor, Joseph Tauber, C Stephen Foster.   

Abstract

OBJECTIVE: To evaluate the demographic characteristics, clinical features, ocular complications, and disease associations of patients with scleritis and episcleritis; as well as to delineate the risk factors for decreased vision in patients with scleritis.
DESIGN: Retrospective case series. PARTICIPANTS: Five hundred patients with scleritis and 85 patients with episcleritis.
METHODS: The electronic health records of 500 patients with scleritis and 85 patients with episcleritis seen at 2 tertiary referral centers were reviewed and their clinical features were studied. MAIN OUTCOME MEASURES: Clinical features (pain, scleral inflammation), ocular complications (decrease in vision, anterior uveitis, peripheral ulcerative keratitis, ocular hypertension), and disease associations.
RESULTS: In a series of 585 patients, 500 patients had scleritis (85.5%) and 85 patients had episcleritis (14.2%). Ocular complications were more frequent overall in patients with scleritis versus in those with episcleritis (45.0% vs. 19.0%), including decrease in vision (15.8% vs. 2.3%), anterior uveitis (26.4% vs. 16.5%), peripheral ulcerative keratitis (7.4% vs. 0%), and ocular hypertension (14.2% vs. 3.5%; P<0.0001 for each). Disease association was observed in 35.8% of patients with scleritis versus 27.1% of episcleritis patients, including connective tissue or vasculitic diseases in 24.8% versus 15.3%, respectively. Scleritis preceded systemic disease diagnosis in 38.7% of patients. Ocular complications (90.0%) and disease association (80.0%) occurred most often in patients with necrotizing scleritis (P<0.0001 for each). Risk factors for decrease in vision in patients with scleritis included necrotizing scleritis (odds ratio [OR], 6.63; P<0.001), posterior scleritis (OR, 2.33; P = 0.042), degree of scleral inflammation of more than 2+ (range, 0-4+; OR, 3.60; P<0.001), anterior uveitis (OR, 1.78; P = 0.033), ocular hypertension (OR, 3.19; P<0.001), and associated disease (OR, 2.66; P<0.001), mainly infectious (OR, 4.44; P<0.001).
CONCLUSIONS: Scleritis is associated more often with ocular complications than episcleritis, and necrotizing scleritis is the type of scleritis most often associated with ocular complications and disease association. Risk factors for decrease in vision in patients with scleritis include necrotizing scleritis, posterior scleritis, scleral inflammation of more than 2+, anterior uveitis, ocular hypertension, and associated infectious disease. FINANCIAL DISCLOSURE(S): The author(s) have no proprietary or commercial interest in any materials discussed in this article.
Copyright © 2012 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21963265     DOI: 10.1016/j.ophtha.2011.07.013

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  38 in total

Review 1.  Ocular vasculitis.

Authors:  Gabriela M Espinoza; Ankit Desai; Levent Akduman
Journal:  Curr Rheumatol Rep       Date:  2013-09       Impact factor: 4.592

2.  Clinical characteristics and ocular complications of patients with scleritis in Japanese.

Authors:  Rie Tanaka; Toshikatsu Kaburaki; Kazuyoshi Ohtomo; Mitsuko Takamoto; Keiko Komae; Jiro Numaga; Yujiro Fujino; Makoto Aihara
Journal:  Jpn J Ophthalmol       Date:  2018-05-23       Impact factor: 2.447

3.  Identification of susceptibility SNPs in CTLA-4 and PTPN22 for scleritis in Han Chinese.

Authors:  F Li; X Ma; L Du; L Shi; Q Cao; N Li; T Pang; Y Liu; A Kijlstra; P Yang
Journal:  Clin Exp Immunol       Date:  2019-04-16       Impact factor: 4.330

4.  Occult Fungal Scleritis.

Authors:  Lauren J Jeang; Aaron Davis; Brian Madow; Edgar M Espana; Curtis E Margo
Journal:  Ocul Oncol Pathol       Date:  2016-09-14

5.  Ocular inflammation associated with relapsing polychondritis in Japanese patients: a review of 11 patients.

Authors:  Rie Tanaka; Toshikatsu Kaburaki; Hisae Nakahara; Keiko Komae
Journal:  Int Ophthalmol       Date:  2019-05-10       Impact factor: 2.031

Review 6.  Ocular inflammatory diseases associated with rheumatoid arthritis.

Authors:  Mathieu Artifoni; Pierre-Raphaël Rothschild; Antoine Brézin; Loïc Guillevin; Xavier Puéchal
Journal:  Nat Rev Rheumatol       Date:  2013-12-10       Impact factor: 20.543

Review 7.  Pharmacotherapy of scleritis: current paradigms and future directions.

Authors:  Robert M Beardsley; Eric B Suhler; James T Rosenbaum; Phoebe Lin
Journal:  Expert Opin Pharmacother       Date:  2013-02-21       Impact factor: 3.889

8.  Incidence of scleritis and episcleritis: results from the Pacific Ocular Inflammation Study.

Authors:  Gelareh Homayounfar; Natalie Nardone; Durga S Borkar; Vivien M Tham; Travis C Porco; Wayne T A Enanoria; John V Parker; Aleli C Vinoya; Aileen Uchida; Nisha R Acharya
Journal:  Am J Ophthalmol       Date:  2013-07-24       Impact factor: 5.258

9.  Five-year outcome in immune-mediated scleritis.

Authors:  Wolfgang Bernauer; Beat Pleisch; Matthias Brunner
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-07-10       Impact factor: 3.117

10.  Ahmed glaucoma valve surgery for necrotizing scleritis with secondary glaucoma.

Authors:  Abhishek Ranjan; Aparna Rao
Journal:  Int Ophthalmol       Date:  2013-05-01       Impact factor: 2.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.